Загрузка...
Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells
Molecular tumour targeting has significantly improved anti-cancer protocols. Still, the addition of molecular targeting to the treatment regime has not led to a curative breakthrough. Combined mammalian target of Rapamycin (mTOR) and histone deacetylase (HDAC) inhibition has been shown not only to e...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4124028/ https://ncbi.nlm.nih.gov/pubmed/24779401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12299 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|